Abstract:Simple synthesis of customisable antibody‐drug conjugates (ADCs) and bispecific antibodies by integration of well‐established bioengineering and click‐chemistry methods, yielding high reaction efficiency and site specificity while retaining antibody functionality; here showcased through bioorthogonal functionalisation of nanobodies and single‐chain variable fragments (scFv) with a selection of model fluorescein isothiocyanate (FITC) and polyethylene glycol (PEG) based materials. Protein functionalisation for the development of imaging agents and antibody drug conjugates still often relies on statistical amidation of the protein through accessible lysine and cysteine residues, requiring protein to protein conjugation optimisation and can potentially impact the overall function. To combat this, focus has turned to developing proteins that have noncanonical amino acids incorporated into their structure, allowing for site‐specific labelling and functionalisation. Herein we showcase the incorporation of non‐canonical amino acids bearing a tetrazine or azide orthogonal coupling modality into biologics targeted to the prostate‐specific membrane antigen and epidermal growth factor receptor respectively. The placement of these bioorthogonal residues into nanobody or single chain variable fragments (scFvs) is introduced by site‐directed mutagenesis of the protein‐coding DNA that allows for controlled insertion when these proteins are expressed. We show that bioorthogonal coupling of model compounds such as fluorophore or polymeric materials onto the protein does not significantly change the binding affinity, making these protein conjugation methods a powerful tool for development of simple customisable personalised targeted antibody‐drug conjugates where affinity is retained.

Optical control of nanobody-mediated protein activity modulation with a photocleavable fluorescent protein

Characterization of a nanobody-epitope tag interaction and its application for receptor engineering

Aptamer-based optical manipulation of protein subcellular localization in cells

Reversible and Quantitative Photoregulation of Target Proteins

Turning antibodies off and on again using a covalently tethered blocking peptide

Near-infrared Photoactivatable Control of Ca2+ Signaling and Optogenetic Immunomodulation

Tracking the Fate of Therapeutic Proteins Using Ratiometric Imaging of Responsive Shortwave Infrared Probes

Creating Red Light-Switchable Protein Dimerization Systems As Genetically Encoded Actuators with High Specificity

Optical Actuation of Inorganic/Organic Interfaces: Comparing Peptide-Azobenzene Ligand Reconfiguration on Gold and Silver Nanoparticles

Quantitative control of subcellular protein localization with a photochromic dimerizer

Spatiotemporally Controlled DNA Nanoclamps: Single-Molecule Imaging of Receptor Protein Oligomerization

Nanobody Technology: A Versatile Toolkit for Microscopic Imaging, Protein–Protein Interaction Analysis, and Protein Function Exploration

Photoswitchable PROTACs for Reversible and Spatiotemporal Regulation of NAMPT and NAD+

Photoswitchable nanofluorophores for innovative bioimaging

Photo-regulated PROTACs: A novel tool for temporal control of targeted protein degradation

Destabilized near-infrared fluorescent nanobodies enable background-free targeting of GFP-based biosensors for imaging and manipulation

Click‐on Antibody Fragments for Customisable Targeted Nanomedicines – Site‐specific Tetrazine and Azide Functionalisation through Non‐canonical Amino Acid incorporation

Bidirectional Regulation of Intracellular Enzyme Activity Using Light‐Driven Nano‐Inhibitors

Light-Activated Nanoprobes for Biosensing and Imaging

Enzymatic Protein Immobilization for Nanobody Array

Nanobody: a promising toolkit for molecular imaging and disease therapy